Joint with: Decoding HIV Persistence: Strategies for Curing HIV Infection
HIV Vaccines: Intersections of Basic and Clinical Science

Apr 16–19, 2026 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers: Penny L Moore, Marit van Gils, and Kevin O. Saunders

  Livestream
  In Person
  On Demand
 Add to Calendar
×

-

Apr 16–19, 2026 | Beaver Run Conference Center, Breckenridge, CO, United States

Scientific Organizers: Penny L Moore, Marit van Gils, and Kevin O. Saunders

Supported by the  Directors' Fund

***Meeting program subject to change.

Available Formats:     = Livestream   = In Person     = On Demand
Thursday, April 16, 2026
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Friday, April 17, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Address (Joint)
8:00–9:00 AM
Alexandra Trkola, University of Zürich
HIV Vaccines: Learning from the Swiss X-BNAb Cohort for Prevention and Cure
Immune Interventions Interfacing HIV Prevention and Cure (Joint)
9:00–11:15 AM
Mauricio A. Martins, University of Florida
Promoting Persistent bNAb Expression in NHPs through AAV-Mediated Gene Transfer
Devi SenGupta, Gilead Sciences, Inc.
Long-acting ART in HIV Prevention and Cure
Leonidas Stamatatos, Fred Hutchinson Cancer Research Center
Vaccination of PLWH, using 426C Derived Immunogens
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Poster Setup
11:15–1:00 PM
On Own for Lunch
11:15–5:00 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Keeping up with the Changing HIV Envelope
5:00–7:00 PM
Penny L Moore, University of the Witwatersrand and National Institute for Communicable Diseases
African bNAb Immunogens
Margaret E. Ackerman, Dartmouth College
Fc Effector Function in HIV Infection and Vaccination
Aime Marcel Simon Tongo Passo, Center for Research on Emerging and Re-Emerging Diseases (CREMER/IMPM)
Viral Diversity in Central Africa: Known and Unknowns
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Saturday, April 18, 2026
Breakfast
7:00–8:00 AM
The Vaccine Pipeline: Integrating Basic and Clinical Insights
8:00–11:00 AM
Speaker to be Announced
Richard T. Wyatt, The Scripps Research Institute
Triggering bNAbs in Non-Human Primates
Persephone Borrow, University of Oxford
Creating an Immune Environment Favorable for HIV-1 bnAb Induction
Louis J. Picker, Oregon Health & Science University
Progress in CMV based Vaccines
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Panel: Perspectives: Personalized Medicine & Patient-Centered Strategies (Joint)
1:30–2:45 PM
Career Roundtable (Joint)
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Targeting the Needle in the Haystack: Clinical Trials of Germline Targeting Immunogens
5:00–7:00 PM
Kevin O. Saunders, Duke University
Induction of HCDR3-Binding and CD4 Mimicking Antibodies in HVTN300 and HVTN309
Eunice Wambui Nduati, KEMRI, Wellcome Trust
Germline Targeting Immunogens and Precursors in African Populations
Marit van Gils, Amsterdam UMC
Germline Targeting Immunogens in Human Clinical Trials; C101, C107, C110
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Sunday, April 19, 2026
Breakfast
7:00–8:00 AM
Looking to the Future: New Tools, Platforms and Delivery Systems
8:00–11:00 AM
Eric A. Appel, Stanford University
Injectable Hydrogel Depot Technologies for Sustained Delivery of Vaccines
Shannon Miller, Inimmune Corporation
Adjuvants for Mucosal Immunity
Speaker to be Announced
Rory Henderson, Duke University
Large Language Models to Identify bnAbs and Design Vaccines to Them
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
B Cell Responses and Broadly-Neutralizing Antibodies: Trials and Tribulations (Joint)
5:00–6:45 PM
Marina F. Caskey, Rockefeller University
Combined Immunotherapy with IL-15 Agonists and Broadly-Neutralizing Antibodies
Paula M. Cannon, University of Southern California, Keck School of Medicine
Engineering B Cells as in vivo bnAb Factories
William Schief, The Scripps Research and IAVI
Combining Germline Targeting Approaches Across Diverse bNAb Epitopes
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Dinner
7:00–8:00 PM
Cash Bar
8:00–11:00 PM
Entertainment
8:00–11:00 PM
Monday, April 20, 2026
Departure
12:00–11:59 PM

Subscribe for Updates